TERN
Terns Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $658.96M | Price | $8.26 |
| Volume | 1.03M | Change | +1.23% |
| P/E Ratio | -7.4 | Open | $8.08 |
| Revenue | -- | Prev Close | $8.16 |
| Net Income | $-88.9M | 52W Range | $1.87 - $9.03 |
| Div Yield | N/A | Target | $15.83 |
| Overall | 55 | Value | 60 |
| Quality | 42 | Technical | 63 |
No chart data available
Stock Overview
Updated DailyTerns Pharmaceuticals Inc. (TERN) is a leading Manufacturing company in the Medicinal and Botanical Manufacturing industry, currently trading at $8.26 with a market capitalization of $658.96 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows TERN with a volume of 1.03 million shares. The stock opened down 0.98% from yesterday's close of $8.16. Current analyst estimates project earnings of $-1.14 per share for this year, with next year targeting $-1.39.
TERN demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for TERN include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 91.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 06:53 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TERN | $8.26 | +1.2% | 1.03M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Terns Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW